Skip to main content
Log in

Chronic myeloproliferative disorder with ETV6-PDGFRβ fusion gene

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Irusta PM, DiMaio D (1998) A single amino acid substitution in a WW-like domain of diverse members of the PDGF receptor subfamily of tyrosine kinases causes constitutive receptor activation 17(23):6912–6923

    CAS  Google Scholar 

  2. Claesson-Welsh L (1994) Platelet-derived growth factor receptor signals. J Biol Chem 269:32023–32026

    PubMed  CAS  Google Scholar 

  3. Wilkinson K, Velloso ER, Lopes LF et al (2003) Cloning of the t(1;5)(q23;q33) in a myeloproliferative disorder associated with eosinophilia: involvement of PDGFRB and response to imatinib. Blood 102:4187–4190

    Article  PubMed  CAS  Google Scholar 

  4. Apperley JF, Gardembas M, Melo JV et al (2002) Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor. N Engl J Med 347(7):481–487

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eswar Tipirneni.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tipirneni, E., Buttar, A., Brettler, D. et al. Chronic myeloproliferative disorder with ETV6-PDGFRβ fusion gene. Ann Hematol 91, 637–638 (2012). https://doi.org/10.1007/s00277-011-1296-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-011-1296-y

Keywords

Navigation